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Abstract
Background: By assaying hundreds of thousands of single nucleotide polymorphisms, genome
wide association studies (GWAS) allow for a powerful, unbiased review of the entire genome to
localize common genetic variants that influence health and disease. Although it is widely recognized
that some correction for multiple testing is necessary, in order to control the family-wide Type 1
Error in genetic association studies, it is not clear which method to utilize. One simple approach is
to perform a Bonferroni correction using all n single nucleotide polymorphisms (SNPs) across the
genome; however this approach is highly conservative and would "overcorrect" for SNPs that are
not truly independent. Many SNPs fall within regions of strong linkage disequilibrium (LD)
("blocks") and should not be considered "independent".
Results: We proposed to approximate the number of "independent" SNPs by counting 1 SNP per
LD block, plus all SNPs outside of blocks (interblock SNPs). We examined the effective number of
independent SNPs for Genome Wide Association Study (GWAS) panels. In the CEPH Utah (CEU)
population, by considering the interdependence of SNPs, we could reduce the total number of
effective tests within the Affymetrix and Illumina SNP panels from 500,000 and 317,000 to 67,000
and 82,000 "independent" SNPs, respectively. For the Affymetrix 500 K and Illumina 317 K GWAS
SNP panels we recommend using 10-5, 10-7 and 10-8 and for the Phase II HapMap CEPH Utah and
Yoruba populations we recommend using 10-6, 10-7 and 10-9 as "suggestive", "significant" and "highly
significant" p-value thresholds to properly control the family-wide Type 1 error.
Conclusion: By approximating the effective number of independent SNPs across the genome we
are able to 'correct' for a more accurate number of tests and therefore develop 'LD adjusted'
Bonferroni corrected p-value thresholds that account for the interdepdendence of SNPs on well-
utilized commercially available SNP "chips". These thresholds will serve as guides to researchers
trying to decide which regions of the genome should be studied further.
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Since first proposed in 1996 by Risch and Merikangas [1],
it has increasingly been accepted that association studies
are powerful to detect modest effects of common alleles
involved in complex trait susceptibility. Until recently,
genotype-phenotype tests of association have been lim-
ited to candidate genes. Recent advances in molecular
technologies and the availability of the human genome
sequence have revolutionized researchers' ability to cata-
logue human genetic variation. In addition, the Interna-
tional HapMap project has provided researchers with
invaluable information regarding the linkage disequilib-
rium (LD) structure within the genome [2,3]. These
advances have made genome wide association studies
(GWAS) to identify common variants a reality. However
many issues regarding the design, analysis and interpreta-
tion of results remain to be investigated.
In particular, interpretation of results is not trivial in light
of the scale of multiple testing proposed. Testing such a
large number of SNPs will require a balance between
power and the chance of making false discoveries. There
are many methods that have been proposed to address the
multiple testing issue. These include false discovery rate
(FDR), permutation testing, Bayesian factors (BF) and the
Bonferonni correction. The FDR controls the expected
proportion of false positives among all rejections, provid-
ing a less stringent control of the Type I error [4]. The
application of the FDR method specifically in the context
of genome wide studies has been proposed [4-6]. Permu-
tation testing, in which the datasets are permuted thou-
sands of times to achieve genomewide significance is
another method that has been used in candidate gene
studies and now genome wide association studies [7,8].
Although empirical p-values have a theoretical advantage
they may be computationally infeasible with large data-
sets. Another proposed method is the use of Bayesian Fac-
tors (BF) instead of frequentist p-values which need to be
interpreted with the power of the study. However, BF also
requires an assumption about the effect size, but the
major advantage is that it can be compared across studies
[9]. A simple method to control the family-wise error rate
is the Bonferroni correction, which adjusts the Type 1
error (a) by the total number of tests (a/n). The Bonfer-
roni correction can use the actual number of tests per-
formed (i.e. SNPs genotyped) or a theoretical value based
on the total number of tests possible (i.e. all SNPs). One
critical, but often overlooked, assumption, of the Bonfer-
roni correction method, is the assumption that all the
tests are independent [10]. Biologically, we know that
SNPs in close proximity are not independent, and there-
fore we are "overcorrecting" when we use the traditional
Bonferroni method to adjust significance thresholds for
multiple testing in GWAS studies [11]. We propose Bon-
ferroni corrected p-value thresholds that account for the
interdepdendence of SNPs on commonly used commer-
cially available SNP "chips" (Illumina 317 K and Affyme-
trix 500 K) and in the HapMap panels. This method is an
extension of the Bonferroni correction that accounts for
the underlying linkage disequilibrium or dependence in
dense SNP panels. These thresholds will be invaluable to
researchers as they can be used as a guide to identifying
regions of interest or significance in genome wide associ-
ation studies, which should be studied further.
Methods
In order to estimate the effective number of "independ-
ent" SNPs in 3 autosomal marker panels (HapMap, Illu-
mina 317 K and Affymetrix 500 K) we downloaded
genotype data from release 22 of the International Hap-
Map project. We used the non-redundant CEU and YRI
data mapped against the "rs strand" of build 36 of the
human genome. For the Illumina and Affymetrix marker
sets we used a perl script to generate chromosome specific
files containing only the subset of specific markers
included in the Illumina 317 K or Affymetrix 500 K panels
using CEU data. Then for each chromosome of data we
used a perl script to generate smaller more manageable
files each containing genotype data for approximately
2500 SNPs. We used Haploview version 4.0 to evaluate
blocks of linkage disequilibrium (LD) using the 'Solid
Spine of LD' algorithm with a minimum D' value of 0.8.
The Solid Spine of LD method internal to Haploview
defines a block when the first and last markers are in
strong LD with all intermediate markers. We also evalu-
ated chromosome 1 for the CEU HapMap data using the
"Solid Spine of LD' algorithm and varying the minimum
D' value to 0.7 and 0.9 to determine if this value altered
the thresholds. In addition, we evaluated chromosome 1
for the CEU HapMap data using the Gabriel and 4-gamete
block defining methods. For all analyses we ignored pair-
wise comparisons of markers >500 kb apart and excluded
individuals with >50% missing genotypes. We also
excluded markers with a minor allele frequency less than
0.01, a Hardy-Weinberg equilibrium p-value less than
0.001 or a genotype call rate less than 75%. We then sum-
marized across the genome: Total number of SNPs, Total
number of Blocks, Total number of SNPs not in a block
(inter-block SNPs) and Total number of blocks + inter-
block SNPs for each panel. Our programs are available
upon request so that thresholds can be established per
population.
Results and discussion
We established three thresholds that correspond to 1) sug-
gestive association in which we expect 1 false positive
association per GWAS 2) significant association in which
we expect one false positive association to occur 0.05
times per GWAS and 3) highly significant association in
which we expect one false positive association to occurPage 2 of 8
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tion, by considering the interdependence of SNPs, we
reduced the total number of effective tests within the
Affymetrix and Illumina SNP panels from 500,000 and
317,000 to 67,000 and 82,000 "independent" SNPs,
respectively (Tables 1 and 2). This results in p-value
thresholds of ≈10-5, 10-7 and 10-8 for both the Affymetrix
and Illumina SNP panels (Table 3) compared to ≈10-6, 10-
7 and 10-9 if we do not correct for the lack of independence
among SNPs. For researchers using these set genome-wide
SNP panels this provides valuable thresholds to interpret
association results, and to identify SNPs that may be
important for replication.
In addition to the established SNP panels, we evaluated
the number of "independent" tests within the Phase II
HapMap publicly available data for both the CEPH from
Utah (CEU) and Yoruba (YRI) populations. Since our pro-
posed thresholds are LD block dependent, they are popu-
lation specific and the total number of "independent"
SNPs may vary across populations and therefore should
be considered separately. The publicly available data
includes 2.4 million (CEU) and 2.7 million (YRI) SNPs
across the genome. We reduced the total number of tests
to 164,000 SNPs and 289,000 SNPs for the CEU and YRI,
respectively (Tables 4 and 5). This results in p-value
thresholds of ≈10-6, 10-7 and 10-9 for both the CEU and
YRI populations (Table 3) compared to ≈10-7, 10-8 and
10-10 if we do not correct for the lack of independence
among SNPs. The total number of "independent" SNPs
for the YRI population is nearly double that for the CEU,
however this does not have an impact on the exponent of
the p-value. As expected, as the density of SNPs increases,
the average number of SNPs within a block also increases.
Therefore, it is likely that the additional Affymetrix and
Illumina SNP panels (1 million and 650,000 SNPs) will
not greatly increase the number of independent SNPs but
will increase the number of SNPs within a block. How-
ever, using the highly dense HapMap population (Tables
4 and 5) provides us with thresholds that can be used for
denser platforms (e.g. 1 million SNPs) or for studies that
utilize statistical methods to impute the 2.5 million+
HapMap SNPs.
We also altered the D' value used to define the blocks from
0.7 to 0.9 for Chromosome 1 in the HapMap CEU popu-
lation to determine if block definition had a large impact
on our results. Using a D' value of 0.7 results in 2,039
fewer "independent" SNPs on chromosome 1 which
extrapolates to 44,000 fewer "independent" SNPs across
the genome. Using a more stringent value of D' = 0.9
results in 2,906 more "independent" SNPs on chromo-
Table 1: Affymetrix 500 K using CEU HapMap Samples
Affymetrix 500,000 SNP Panel (CEU)
Chromosome Total number of SNPs Total number of blocks Total number Interblock 
SNPS
Total number of blocks + 
Interblock SNPs
1 31876 4447 833 5280
2 33610 4626 787 5413
3 27588 3903 723 4626
4 25811 3514 689 4203
5 26548 3601 646 4247
6 26550 3487 604 4091
7 21544 3061 618 3679
8 22550 3053 563 3616
9 19086 2664 541 3205
10 23531 3046 510 3556
11 21477 2761 528 3289
12 20549 2821 499 3320
13 15700 2116 392 2508
14 12839 1820 371 2191
15 11560 1857 396 2253
16 12339 1944 454 2398
17 8473 1385 344 1729
18 11966 1748 374 2122
19 5177 954 305 1259
20 10292 1519 331 1850
21 5873 843 204 1047
22 5053 828 213 1041
Total 399,992 55,998 10,925 66,923Page 3 of 8
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SNPs across the genome. Although this may increase the
range of total SNPs across the genome from 120,000 to
228,000 it does not alter the exponent of the p-value or
substantially affect the thresholds (Table 3).
We also defined blocks using two additional block defini-
tions: the Gabriel method and the 4-gamete rule. The
Gabriel method creates blocks using stringent criteria of
LD with a D' upper bound >0.98 and a lower bound
>0.70[12]. This creates smaller blocks with fewer SNPs
within a block. The 4-gamete rule of Wang, based on Hud-
son and Kaplan determines blocks based on presumed
recombination[13,14]. Using pairwise sets of SNPs it
determines the frequency of observing all 4 possible 2-
SNP haplotypes. If all 4 haplotypes are observed, this
method assumes recombination has occurred. Table 6
shows the results of different block definitions for Chro-
Table 2: Illumina 317 K SNPs using CEU HapMap Samples
Illumina 317,000 SNP Panel (CEU)
Chromosome Total number of SNPs Total number of blocks Total number Interblock 
SNPS
Total number of blocks + 
Interblock SNPs
1 23055 4959 1336 6295
2 25103 5258 1348 6606
3 21332 4505 1268 5773
4 18923 3979 1055 5034
5 19062 3966 979 4945
6 20524 4044 950 4994
7 16493 3472 977 4449
8 18053 3658 940 4598
9 15691 3305 936 4241
10 15423 3263 899 4162
11 14498 3037 827 3864
12 14844 3097 918 4015
13 11411 2373 620 2993
14 9767 2086 592 2678
15 8817 1942 631 2573
16 8924 2078 705 2783
17 8279 1859 603 2462
18 10390 2183 678 2861
19 5833 1408 545 1953
20 7758 1736 496 2232
21 5430 1130 318 1448
22 5398 1156 379 1535
Total 305,008 64,494 18,000 82,494
Table 3: Thresholds for Genome Wide Association Using CEU and YRI Population Samples
Panel Suggestive p values (1) Significant p values (0.05) Highly Significant p values (0.001)
Affymetrix CEU 500 K (n = 66,923) 1.49 × 10-05 7.47 × 10-07 1.49 × 10-08
Illumina 317 K (n = 82,494) 1.21 × 10-05 6.06 × 10-07 1.21 × 10-08
HapMap YRI (n = 289,175) 3.45 × 10-06 1.73 × 10-07 3.45 × 10-09
HapMap CEU (n = 164,296) 6.09 × 10-06 3.04 × 10-07 6.09 × 10-09
HapMap CEU (D' > 0.7)* 8.37 × 10-06 4.19 × 10-07 8.37 × 10-09
HapMap CEU (D' > 0.9)* 4.38 × 10-06 2.19 × 10-07 4.38 × 10-09
*extrapolated from Chromosome 1 data. P-values in parentheses in the header line indicate the family-wide error rate that corresponds to the 
Bonferroni-corrected significance thresholds given in the columns below.Page 4 of 8
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method results in a similar number of blocks, but the
number of SNPs per block is greatly reduced resulting in
more SNPs outside of the block that are still in LD but do
not meet the stringent criteria of a "block". The 4-gamete
rule results in fewer blocks and more SNPs outside of
blocks that represent potential recombination events. To
limit the dependence on LD we believe the solid spine of
LD is the best method to capture the underlying LD and
biological dependence of SNPs, and therefore we base our
thresholds on this method.
The method we detail is an extension to the original Bon-
ferroni correction which is widely utilized; however, we
have reduced the total number of SNPs to reflect the
number of "independent SNPs" since independence is an
assumption of the Bonferroni correction. Therefore, our
thresholds are based on the original Bonferroni calcula-
tion of 1/Total # of SNPs, 0.05/Total # of SNPs and 0.001/
Total # of SNPs where the number of SNPs that we use is
now a better estimate of the number of independent tests
being performed. Therefore, our proposed method allows
a Bonferroni correction that has less violation of the
assumption of independence.
We have empirically defined thresholds for genome wide
association studies to control the family-wise error rate
while accounting for the interdependence of SNPs in link-
age disequilibrium. The use of actual data provides us an
opportunity to unequivocally characterize the underlying
linkage disequilibrium structure in these two populations.
We considered the use of simulations as has been done for
single chromosomes by assigning haplotypes based on
frequencies from inferred haplotypes of founders for a set
number of replicates [11]. But the reality is that simula-
tion programs have thus far been unable to recreate the
complexity of the underlying LD structure of the human
genome. While we could use real 500 K genotype data and
simulate unassociated traits, we would need to obtain
many real 500 K GWAS data sets and then simulate many
replicates of unassociated traits in each of them to ade-
quately examine Type I error. Currently, this is a daunting
task since the process just for obtaining the data from pub-
lic databases is quite lengthy and the analysis time
required to perform hundreds of GWAS analyses would
be prohibitive.
By identifying the "independent" SNPs, we have signifi-
cantly reduced the total number of SNPs to be used for
Bonferroni correction in the set of SNP panels (Affymetrix
and Illumina) and in HapMap. These "independent"
SNPs provide us with a more accurate number of SNPs to
include when adjusting for multiple testing using the Bon-
ferroni correction. In addition, these p-values can assist in
Table 4: HapMap SNPs using CEU HapMap Samples
CEPH Utah HapMap Samples
Chromosome Total number of SNPs Total number of blocks Total number Interblock 
SNPS
Total number of blocks + 
Interblock SNPs
1 184403 10740 1815 12555
2 211913 11219 1510 12729
3 166801 9431 1426 10857
4 155953 10204 1745 10363
5 161666 8725 1238 9963
6 174458 8677 1743 10420
7 137148 8050 1140 9190
8 141925 7707 1076 8783
9 116824 7092 1105 8197
10 132087 7428 1250 8607
11 124354 6821 1037 7858
12 118973 6959 991 7950
13 99669 5290 793 6083
14 80500 4690 893 5583
15 69104 4690 814 5504
16 68205 5212 817 6029
17 56026 4127 715 4842
18 73392 4486 742 5228
19 35412 3109 570 3679
20 60421 3896 606 4502
21 32740 2141 380 2521
22 33369 2491 421 2853
Total 2,435,343 143,185 22,827 164,296Page 5 of 8
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only studies which can attain suggestive or significant
association are pursued. We acknowledge that although
we reduce the number of independent SNPS, the corre-
sponding p-value cutoffs are still very low because we are
analyzing more than 2 million SNPs without a specific
biological hypothesis and stringency is still important. We
need to balance identifying a true association while limit-
ing Type 1 error.
We did evaluate the effects of the new thresholds on
power using the Genetic Power Calculator to [15] deter-
mine the sample sizes we would need using a significance
level based on all HapMap SNPs versus only the inde-
pendent SNPs and blocks, as we recommend here. Table
7 provides different sample sizes using the 'LD adjusted'
Bonferroni correction that we suggest here and the unad-
justed Bonferroni correction in both CEU and YRI Hap-
Map samples. Using the unadjusted Bonferroni correction
would result in a necessary increase in sample size of 358–
890 cases depending on the genotype relative risk and
population. This increased burden of sample recruitment,
collection and genotyping to adjust for "all" SNPs needs
to be considered carefully, especially since many of the
SNPs will be in strong LD and not contributing increased
information.
Conclusion
The emerging trend towards genome wide association
studies and large scale SNP genotyping warrants universal
Table 5: HapMap SNPs using YRI HapMap Samples
Yoruba HapMap Samples
Chromosome Total number of SNPs Total number of blocks Total number Interblock 
SNPS
Total number of blocks + 
Interblock SNPs
1 209439 17517 4169 21686
2 238828 19081 5688 24769
3 184337 15409 3635 19044
4 174670 14673 2754 17427
5 176975 14478 3063 17541
6 187787 14073 3127 17200
7 149764 12884 2451 15335
8 158800 13069 2465 15534
9 128582 11602 3185 14787
10 147710 12065 3778 15843
11 136474 11261 2793 14054
12 130298 11142 2383 13525
13 112162 8767 1470 10237
14 88022 7549 1240 8789
15 77885 7979 1657 9636
16 78364 8334 1810 10144
17 62720 6622 1754 8376
18 87027 7466 5294 12760
19 39729 4514 1037 5551
20 68828 6397 1344 7741
21 37450 3717 744 4461
22 36468 3945 790 4735
Total 2,712,319 232,544 56,631 289,175
Table 6: Altering Block Definitions for Chromosome 1
Total Number of Blocks Total Number of
Interblock SNPs




Average D' per block
Solid Spine LD 10740 1815 12555 18.4 0.804
Gabriel 10115 38037 48152 15.7 0.805
4-Gamete Rule 18967 9084 28051 9.5 0.841Page 6 of 8
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Lander and Kruglyak for LOD score genetic linkage analy-
ses [16]. The dilemma facing many researchers is which
regions to follow-up with dense SNPs or sequencing? To
date, the most utilized threshold has been the arbitrary
value set by the Wellcome Trust Case Control Consortium
of 5 × 10-7 [17]. Interestingly, our Bonferroni LD-adjusted
values are similar to these two thresholds (nominal p-
value = 3.04 × 10-7 for CEU), but we also provide thresh-
olds for suggestive and highly significant association. We
believe the suggestive association threshold should be used
to identify SNPs for consideration in follow-up studies,
and both the significant and highly significant associations
should be considered regions more likely of association.
Of course, these thresholds are only guidelines that
account for the interdependency of SNPs and investiga-
tors should carefully consider any regions with strong can-
didate genes or biologic plausibility even if they do not
meet these thresholds. We also agree with the NHGRI/
NCI working group on Replication in Association Studies
that all statistically significant regions should be repli-
cated using additional populations with adequate sample
size to confirm any GWAS finding [18]. These thresholds
should assist in replicating regions of true association.
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